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Abstract 
Drug-loaded core-sheath fibers were successfully prepared from a combination of 
poly(methyl methacrylate) (PMMA) and polycaprolactone (PCL) using a coaxial 
electrospinning system and Nimesulide as an anti-inflammatory drug model. An electric 
field potential of 7-8 kV was found optimal for the formation of the fibers, which were 
characterized using scanning and transmission electron microscopy techniques combined 
with attenuated total reflectance infrared spectroscopy and contact angle measurements. 
Results confirmed the core-sheath morphology and indicated that these fibers are larger 
in diameter than normal ones (prepared as controls from either PCL or PMMA, under 
similar conditions). The prepared core-sheath fibers were also investigated by differential 
scanning calorimetry (DSC) and thermogravimetric analysis (TGA), and results indicated 
that Nimesulide is completely solubilized in the polymer matrix and that its presence 
improved the thermal stability of the core-sheath fibers compared to that of normal 
PMMA fibers. Moreover, PMMA-PCL core-sheath fibers showed an improvement in 
terms of mechanical properties (such as elongation at break) in comparison with pure 
PMMA fibers. Drug release studies demonstrated that the delivery of Nimesulide can be 
modulated by appropriately selecting the loading area, with faster release observed when 
the drug was located in the sheath. Results suggest altogether the significant potential of 
PMMA-PCL core-sheath fibers for applications involving delivery of hydrophobic anti-
inflammatory drugs such as Nimesulide. 
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1. Introduction 
Electrospinning is a versatile technique capable of processing a wide variety of 
materials such as ceramics, metals, glass or organic polymers to form fibers with 
diameters in the nano or micrometre range [1–3], as a result of electrostatic forces caused 
by the attraction of opposite charges between the solution droplets and the collector [4, 
5]. In addition to being non-toxic, biodegradable and biocompatible [6], polymeric fibers 
used in biomedical applications require other important characteristics such as high 
surface area, porosity, malleability or mechanical resistance, which confer them the 
ability to perform appropriately in various roles as drug carriers, for drug solubilization 
or controlled release [7–11]. Drug-loaded fiber systems have the potential to adjust the 
drug dissolution range and to modulate the drug dosage, thus eliminating problems with 
inaccurate dosing while increasing efficacy and reducing toxicity and side effects [12, 
13]. 
Like normal monoaxial fibers, core-sheath (or coaxial) fibers can be generated by 
electrospinning two solutions simultaneously through a coaxial needle, to form fibers 
with one type of material inside (the core) and the other one on the outer side (the sheath), 
as presented in Figure 1. Core-sheath fibers present advantages in comparison to normal 
ones in terms of their mechanical and biological properties [20–23], as well as in terms 
of their potential to modulate drug release [24–27]. These fiber systems offer the potential 
to deliver drugs in a way that avoids side effects found with drugs delivered in solution. 
Nimesulide is a hydrophobic anti-inflammatory drug that is a selective COX-2 
isoform inhibitor, and it has been approved for use in the symptomatic treatment of severe 
pain states [14][15]. However, due to the toxicity manifested in its hepatic metabolism, 
Nimesulide has been strongly regulated and even prohibited in some countries, and novel 
alternatives for the administration of this drug (such as transdermal systems or semi solid 
formulations) have been the focus of recent attention [16–19]. Thus, a method of delivery 
that avoids passage through the hepatic circulation is needed. 
 
Figure 1. a) Schematic representation of the core-sheath fibers electrospinning system. 
 
Poly(methylmethacrylate) (PMMA) is a hydrophobic and amorphous polymer 
used in a range of biomedical, optical or sensor applications [28]; as a result of its good 
biocompatibility, PMMA is of particular interest for the delivery of anti-inflammatory 
and antibiotics drugs in systems such as scaffolds, bone cements, or implants [29]. 
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However, PMMA fibers produced by electrospinning typically have low mechanical 
strength and require reinforcement [30], and to address this limitation we have considered 
in this study using polycaprolactone (PCL). PCL is a synthetic but biodegradable and 
biocompatible polymer that is hydrophobic and semi-crystalline;  PCL is approved for 
use in biomedical applications for several types of devices, and it has been found that it 
imparts good mechanical properties when used in combination with other polymers [31–
34]. Both PMMA and PCL have been suggested in the literature as suitable materials for 
drug delivery systems [35–37], and it has been found that blends of these polymers can 
improve the mechanical properties of fibers investigated for the release of dyes employed 
as model drugs [34]. 
In this paper we report on the preparation by coaxial electrospinning of novel core 
sheath-fibers, alternatively loaded with Nimesulide in each of the two layers, and on the 
evaluation of their potential to deliver such hydrophobic actives. Nimesulide was selected 
as a model drug as this non-steroidal anti-inflammatory active requires innovative 
alternatives for its administration due to its significant hepatotoxicity. The coaxial fibers 
were prepared from a combination of PMMA (core) and PCL (sheath) with the aim to 
improve their mechanical properties while building in the ability to modulate the drug 
release. Results of our investigations of drug-polymer interactions are also reported. 
 
2. Experimental Section 
2.1 Materials 
Polymethylmethacrylate (average Mn = 350,000) and Polycaprolactone (average 
Mn = 35,000) were purchased from Sigma Aldrich. Nimesulide was locally purchased 
(Araújo Manipulações Belo Horizonte - MG). Other chemicals, including 
dimethylformamide (DMF), tethahydrofuran (THF), and dicloromethane (DCM) were 
obtained from Sigma Aldrich and used without further purification. 
 
2.2 Fabrication of Core-Sheath Fibers by Electrospinning 
Normal fibers of pure PMMA and pure PCL were prepared first in order to use 
them as control materials for comparison with the core sheath fibers. PMMA fibers were 
prepared using a solution (12 %w) in DMF:THF (7:3 vol), and PCL fibers were prepared 
using a solution (32 %w) in DCM:DMF (9:1 vol). Concentrations and solvent rations 
were chosen based on preliminary experiments. Electrospun core sheath fibers were then 
prepared by combining the above solutions, which were independently but concomitantly 
5 
 
electrosprayed using a coaxial needle. All fibers were prepared using a Spraybase 
(Avectas) instrument equipped with a programmable syringe pump (World Precision 
Instruments, Florida, US) and a stainless steel coaxial nozzle (Rame-hart Instrument Co, 
NJ, US) with an internal needle diameter of 2.11 mm (outer) and 1.07 mm (inner needle). 
Table 1 presents the parameters used in order to obtain all fiber mats. Where Nimesulide 
was used, the drug was dissolved separately in the above solutions at a concentration of 
6 mg/mL, and two types of fibers were produced: PMMA (core) and PCL (sheath), with 
core-loaded Nimesulide; and, PMMA (core) and PCL (sheath), with sheath-loaded 
Nimesulide. 
 
Table 1: Parameters employed in the fabrication of both normal and core-sheath fibers, 
in the presence or absence of Nimesulide. 
 
2.3 Scanning and Transmission Electron Microscopy studies 
Surface morphology of the core sheath fibers were investigated using a JEOL-
6060LV scanning electron microscope (JEOL Ltd, Japan) operated at 15 kV. Dried 
samples were gold coated for 2 min with a Q150R ES sputter (Quorum Technologies Ltd, 
East Sussex, UK). Samples were also analyzed by transmission electron microscopy 
using a JEOL-2000FX instrument (JEOL Ltd, Japan) at an operating voltage of 80 kV; 
samples were deposited on Formvar coated copper grids (200 Mesh). The fibers diameter 
was determined using at least 60 measurements from three different micrographs, using 
Image J analysis software. 
 
2.4 Contact angle goniometry 
The hydrophobicity of the fibers prepared was investigated on the upper surface 
of the electrospun fiber mats using a contact angle measuring system G10 (Krüss GmbH, 
Germany) by means of sessile drop method measurements, at room temperature, using 
ultrapure water (10 x 10 μL drops). The analysis was performed in triplicate. 
 
2.5 Fourier Transform Infrared Spectroscopy with Attenuated Total Reflectance 
(FTIR-ATR) 
FTIR-ATR spectra were recorded using a Perkin Elmer Spectrum 100 instrument 
equipped with a diamond crystal ATR module (wavelength range 650 to 4000 cm-1; 4 
cm-1 resolution; 36 scans). 
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2.6 Thermal Analysis 
Fibers were investigated by differential scanning calorimetry using a DSC-214 
Polyma instrument (Netzsch, Germany) equipped with a CC203 liquid nitrogen cooling 
accessory. Samples (10 mg) were analyzed over a broad temperature range (-90 to 250 
°C) at a heating rate of 10 °C/min, in nitrogen (2 cycles). Fiber samples (about 15 mg) 
were also investigated by thermogravimetric analysis (TGA), which was performed on a 
TG-209 F1 instrument (Netzsch, Germany), from 20 to 800 °C under nitrogen flow (50 
mL/min), and then in dry air (50 mL/min) from 800 to 1000 °C. 
 
2.7 Water Vapor Permeability 
Water vapor permeability (WVP) was measured with a Payne’s cup (10 mL) using 
a method reported in the literature [38, 39]. Distilled water was used and the polymeric 
fiber samples (cut from the mat obtained by electrospinning as circles with a test area of 
0.95 cm2) were placed in the lid of the cup. The ability of the water vapor to permeate 
through the fiber mats was correlated with the loss of water inside the cup over time. The 
system was placed in a desiccator (with silica gel) that generated a humidity gradient 
across the fiber mat samples mounted in the cup lid. The experiments were performed in 
triplicate, and the water vapor flow (J) was calculated as following, equation 1: 
 
J = Δm/Δt × A         (1) 
 
where Δm/Δt is the angular coefficient of the mass variation versus time (graph 
obtained from the results of the gravimetric measurements of cups), and A is the sample 
surface area (cm2) exposed during the test. 
The water vapor permeability (P) was calculated using the equation (2) below: 
 
P = J x L/ΔPVx(T)        (2) 
 
where J was obtained from Eq. (1), L is the membrane thickness, and ΔPV x (T) 
is the vapor pressure difference (water vapor pressure generate inside of the dessicator) 
at a given temperature (25 ºC). 
 
2.8 Mechanical Properties 
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The burst strength of the fiber mats was evaluated using a TA-XT2 texture 
analyzer instrument (Stable Micro Systems, UK) equipped with a Stable Micro Systems 
film support rig accessory and a 5 mm stainless steel ball probe (D = 5 mm). The velocity 
of the probe was 1 mm.s-1, with a pre-test speed of 2 mm.s-1, and 49 mN as trigger force. 
The results were expressed as puncture strength (PS) and elongation at break (EB; %), 
which were calculated according to equations 3 and 4 [38]: 
 
𝑃𝑃𝑃𝑃 = 𝐹𝐹
𝐴𝐴
          (3) 
 
where Ps (N.mm-2) is puncture strength, F (N) is the force leading to the rupture 
of the film and A (mm2) is the sectional area of the fiber mats used in the experiment. The 
area was calculated as A = 2rh, where r (mm) is the radius of the clamping accessory hole 
and h is the fiber mat’s thickness; 
 
𝐸𝐸𝐸𝐸 = √𝑟𝑟2+𝑑𝑑2−𝑟𝑟
𝑟𝑟
× 100        (4) 
 
where r (mm) is the radius of exposed fibers and d (mm) is the displacement 
caused by the applied force. The experiments were performed in triplicate. 
 
2.9 In vitro drug release studies 
 The release of Nimesulide loaded into the core-sheath fibers was evaluated in vitro 
under static diffusion conditions using Franz cells [40–42]. The Nimesulide content in 
each type of fiber was determined from the electrospinning process parameters using 
equations 7 and 8. The amount of Nimesulide was found to be 2.552 ±1.60 % for fibers 
where the drug was loaded in the core and 1.176 ±0.06 % for those where the drug was 
loaded in the sheath. Samples of both fiber mats were cut with an approximate diffusional 
area of 1 cm2, accurately weighed, and then placed in separate Franz cells. For each cell, 
both compartments were filled with a saline phosphate buffer pH 7.4 (1 mL in the donor 
compartment and 3.6 - 3.8 mL in the receiving compartment), with a 5×2 mm magnetic 
stirrer bar added to the receiving compartment. To increase the solubility of the drug in 
the receiving compartment, 0.1 %w of Soluplus® was added to the saline phosphate buffer 
solution. Synthetic cellulose acetate membranes (molecular weight cutoff 12–14 kDa) 
were used to support the fiber mat samples; they were cut into circular pieces (2.4 cm of 
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diameter) and mounted to adequately cover the receiving chamber. The Franz cells were 
submerged in a temperature controlled (37 ºC) shaker incubator. For each sample, a set 
volume (0.4 mL) of liquid from the receptor compartment was sampled at predetermined 
time intervals, and was replaced by an equal volume of preheated saline phosphate buffer 
also containing Soluplus®. Samples were analyzed using High Performance Liquid 
Chromatography (HPLC), performed with an Agilent instrument equipped with a UV 
detector (Agilent Technologies 1100 series/1200 detector) and a C8 column (4.6 mm x 
25 cm) with water/acetonitrile (1:1 v/v) as mobile phase to determine the concentration 
of each sample collected (Cn). The analysis was performed in triplicate and the 
cumulative release profile was represented as % Nimesulide released over time 
(calculated using equation 6): 
 
Mt=(Cn x V +∑(Cn-1×0.4))        (5) 
 % drug released = Mt
M∞
 𝑥𝑥 100        (6) 
 
where Mt (µg) is the cumulative mass of drug released up to time point t (h), when 
the nth sample was collected (calculated using equation 5); Cn (µg/mL) is the 
concentration of the nth sample (as determined by HPLC) and V (mL) is the total volume 
of the receptor solution in the Franz Cell (V = 3.6 - 3.8 mL). ∑(Cn-1×0.4) represents the 
total mass of drug that has been previously removed (with the n-1 samples that were 
collected earlier). M∞ is the total mass of Nimesulide loaded in the sample that was 
subjected to the test, and has been determined from the concentration (C; g/mL) and flow 
rate (F; mL/h) of each solution employed in the process of electrospinning, using 
equations 7 and 8. 
 
M∞(Nim core)= (𝐹𝐹𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃×𝐶𝐶𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁 )[(𝐹𝐹𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃×𝐶𝐶𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)+(𝐹𝐹𝑃𝑃𝑃𝑃𝑃𝑃×𝐶𝐶𝑃𝑃𝑃𝑃𝑃𝑃) +(𝐹𝐹𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃×𝐶𝐶𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁) × 𝑃𝑃𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑠𝑠𝑠𝑠𝑃𝑃𝑃𝑃  (7) 
 
M∞(Nim sheath)= (𝐹𝐹𝑃𝑃𝑃𝑃𝑃𝑃×𝐶𝐶𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁 )[(𝐹𝐹𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃×𝐶𝐶𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)+(𝐹𝐹𝑃𝑃𝑃𝑃𝑃𝑃×𝐶𝐶𝑃𝑃𝑃𝑃𝑃𝑃) +(𝐹𝐹𝑃𝑃𝑃𝑃𝑃𝑃×𝐶𝐶𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁) × 𝑃𝑃𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑠𝑠𝑠𝑠𝑃𝑃𝑃𝑃 (8) 
 
 
2.10 Statistical analysis 
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The results were analyzed using One-way ANOVA followed by Tukey's Multiple 
Comparison Test, using GraphPad Prism 5.0 software. The subscript letters used in tables 
indicate the subdivision in groups as a result of Tukey’s post-test; differences were 
considered statistically significant where p < 0.05. 
 
3. Results and discussion 
3.1 Preparation of core-sheath fibers and morphology investigations 
Core-sheath fibers based on a combination of PMMA and PCL were successfully 
fabricated by electrospinning, with good reproducibility, using a coaxial system, as 
described in the experimental section. The optimization of the factors that typically 
influence the electrospinning process [8][43] was carried out in preliminary experiments, 
and the main parameters are summarized in Table 1. As an example, Figure 2 presents 
the formation of the Taylor’s cone during the electrospinning process of PMMA/PCL 
core-sheath fibers. 
 
Figure 2. Optical image of the Taylor’s cone during the fabrication of the PMMA/PCL 
core-sheath fibers. 
 
The morphology investigations indicated that all fibers present a well-defined cylindrical 
shape (Figure 3), without typical drops or beads previously reported in the literature [34]. 
The diameters of the fibers, as measured from the SEM images, are presented in Table 2. 
These results are in agreement with similar data reported in the literature that indicate that 
core-sheath fibers, as a result of the electrospinning setup, are normally larger in diameter 
than the normal ones [24]; this was confirmed by statistical analysis (p < 0.05). Results 
of TEM studies (Figure 4) endorse the core-sheath morphology of the fibers prepared. 
 
Table 2. The average diameter of the fibers. 
 
Figure 3. SEM images of: a) normal PCL fibers; b) normal PMMA fibers; c) core-
sheath fibers of PMMA (core) and PCL (sheath), with core-loaded Nimesulide; d) core-
sheath fibers of PMMA (core) and PCL (sheath), with sheath-loaded Nimesulide. 
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Figure 4. TEM images of the core-sheath fibers with PMMA (core) and PCL (sheath), 
with core-loaded Nimesulide: a) 800x magnification; b) 3000x magnification (scale bars 
20 µm). 
 
3.2 Fourier Transform Infrared Spectroscopy with Attenuated Total Reflectance 
(FTIR-ATR) 
Stretching vibrations associated with the C=O groups present in PMMA and PCL 
polymers were observed around 1720 cm-1, and those associated with the C–O bonds 
were observed in the regions 1190-1140 cm-1 for PMMA and 1239-1160 cm-1 for PCL 
(Figure 5). C-H stretching and bending vibrations appeared at 3000-2869 cm-1 and 1472-
1430 cm-1, respectively, in agreement with previous data reported in the literature [44] 
[45]. Absorption bands characteristic to pure Nimesulide are due to N-H stretching 
vibrations (3280 cm-1), however these were not clearly observed for the Nimesulide-
loaded fibers, likely due to the low concentration of drug present. Consequently, no 
significant difference was observed between the FTIR spectra of core-sheath fibers 
having Nimesulide loaded in the core and those having Nimesulide loaded in the sheath. 
It was however noticeable that the FTIR spectra of the core-sheath fibers were more 
similar to that of normal PCL, in particular in the C-H stretching region, evidencing the 
core-sheath structure with PCL as the outer component (considering the maximum 
penetration depth of up to 2 microns for the ATR technique [46]). 
 
Figure 5. FTIR-ATR spectra of: a) pure Nimesulide; b) normal PMMA fibers; c) normal 
PCL fibers; d) core-sheath fibers (PMMA core / PCL sheath); e) core-sheath fibers 
(PMMA core / PCL sheath) with sheath-loaded Nimesulide; f) core-sheath fibers 
(PMMA core / PCL sheath) with core-loaded Nimesulide. 
 
3.3 Thermal Analysis 
The drug-polymer interactions in the prepared core-sheath fibers were 
investigated by dynamic scanning calorimetry (DSC) [47]. The glass transition 
temperature (Tg) of PMMA observed in the normal electrospun fibers (110 ºC) is in 
accordance with literature data [47][28][48], however the observed Tg value for the 
PMMA/PCL core-sheath fibers (without Nimesulide) was 132 ºC, suggesting a 
significant constraint in the movements of the PMMA chains. The core-sheath fibers with 
Nimesulide present in the sheath showed a Tg value of 131 ºC, while the same type of 
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fibers with Nimesulide located in the core had a Tg value of 105 ºC; the lower value 
observed for the latter suggests a significant increase in this case in the PMMA polymer 
chain mobility, similar to observations reported in the literature for polymer matrix based 
composites [47]. It can be suggested that the presence of a strong polar group 
(sulphonamide) in the molecule of Nimesulide could interfere with the dominant 
hydrophobic interactions between PMMA or PCL macromolecules and result in a higher 
mobility of the polymer chains. Moreover, the fact that no endothermic drug melting peak 
(near 150 ºC, as characteristic to pure Nimesulide) could be observed in the DSC 
thermograms of the Nimesulide-loaded core-sheath fibers suggests that the drug is not 
present in the loaded fibers in its crystalline form [15]. 
The melting point (Tm) of PCL did not present significant differences for different 
types of fibers; the Tm value for pure PCL fibers was observed at 60 ºC, and for core-
sheath fibers (without drug) at 61 ºC. A similar value (60 ºC) was detected for the core-
sheath fibers with Nimesulide alternatively located in each layer. 
 
Figure 6. DSC thermograms for: a) pure Nimesulide; b) normal PCL fibers; c) core-
sheath fibers (without drug); d) core-sheath fibers with core-loaded Nimesulide; e) core-
sheath fibers (without drug); d) core-sheath fibers with sheath-loaded Nimesulide; and, 
f) normal PMMA fibers. Left side: expansion for the Tm region characteristic to PCL. 
Right side: expansion for the Tg region characteristic to PMMA. 
 
Results of thermogravimetric analysis evidenced a two-step thermal degradation 
of high molecular weight PMMA. The first one, between 200-290 ºC, is likely a result of 
the homolytic scission of the polymer chain; the second one, between 300-400 ºC, is 
described in the literature as corresponding to the cleavage of the monomers resulting in 
the formation of new radicals, quickly degraded via random scissions [28][48][49]. For 
normal, pure PCL fibers, the decomposition was found to occur in a single stage, at 410 
ºC, in accordance with literature reports that explain it as a consequence of polyester chain 
rupture via cis-elimination reaction and unzipping depolymerization from the ends of the 
polymer chain [50]. 
The first derivative thermograms (dTG, presented in Figure 7) indicate that the 
peak corresponding to the first degradation step of PMMA appears at a higher temperature 
in the core-sheath fibers (300 °C) compared to the normal PMMA fibers (287 °C). A 
similar behavior was observed for the core-sheath fibers loaded with Nimesulide either 
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in the sheath (320 °C) or in the core (325 °C), demonstrating the presence of drug-polymer 
interactions that appear to improve the thermal stability of the system. 
 
Figure 7. First derivative thermograms of: a) pure Nimesulide; b) normal PMMA fibers; 
c) normal PCL fibers; d) core-sheath fibers (no drug); e) core-sheath fibers with sheath-
loaded Nimesulide; f) core-sheath fibers with core-loaded Nimesulide. 
 
3.4 Mechanical properties 
The results of the determination of puncture strength (PS) and elongation at break 
(EB) are presented in Table 2. The poor mechanical properties of normal PMMA fibers 
obtained by electrospinning were evident during the fabrication of these fibers, when 
breaking could sometimes be observed; the reinforcing effect of PCL, known for its 
superior mechanical properties, was clearly noticeable. The different thickness of the 
fiber mats was accounted for using Equation 4, which allowed the calculation of PS and 
EB values (Table 3). It can be seen that elongation at break was significantly higher for 
core-sheath fibers when compared to normal PMMA fibers (while still lower than that 
obtained for pure PCL fibers, though this was to be expected [51][34]). 
 
Table 3. PS and EB values for normal and core-sheath fibers. 
 
3.5 Contact Angle Goniometry 
Measurements of the wetting ability of a surface can provide important 
information on its hydrophilicity [35][52], which is relevant for drug release as this 
process is ultimately controlled by the interactions between the polymer and the 
surrounding aqueous medium. Results of contact angle measurements using deionized 
water droplets revealed lower values for the core-sheath fibers containing Nimesulide 
compared to pure polymer fibers (Table 4); this indicates that the hydrophilicity of the 
materials was significantly increased by the addition of the drug, which appears to interact 
strongly with both polymers as evidenced also by the results of thermal analysis.  
 
Table 4. Results of contact angle measurements for normal and core-sheath fibers. 
 
3.6 Water Vapor Permeability 
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Water Vapor Permeability (WVP) is indicative of the barrier capacity of the fiber 
mats, and can be defined as the rate of transmission of water vapor through a flat surface 
by the unit of thickness, at specified temperature and humidity conditions [53]. The vapor 
permeation process is driven by the vapor pressure difference across the fiber mat, which 
acts as a membrane, and the barrier capacity is the result of a combination of several 
factors such as mat structure and porosity, hydrophilicity, and polymer compatibility 
[38][54]. The results of thickness and water vapor permeability measurements are 
presented in Table 5. The core-sheath fibers presented higher WVP values in comparison 
with normal fibers made of pure polymers. In line with the results obtained from the 
contact angle measurements, it appears that the presence of Nimesulide makes the fibers 
more hydrophilic, with a lower contact angle and higher vapor permeability. 
 
Table 5. Results of water vapor permeability (WVP) measurements. 
 
3.7 Drug release studies 
Drug release investigations were carried out in Franz cells, in saline phosphate 
buffer pH 7.4, under static diffusion conditions. The release of Nimesulide was monitored 
by HPLC and the cumulative drug release data is represented in Figure 8. The content of 
Nimesulide loaded in the core-sheath fibers was 25.52 mg per g of fiber (when core-
loaded) and 11.76 mg per g fiber (when sheath-loaded), as determined using equation 7. 
Perhaps unsurprisingly, results indicate that the drug release was faster (and more 
complete) from the fibers where the drug was loaded in the sheath compared to those 
where the drug was loaded in the core, and where the diffusion path was longer. After 20 
h, almost half of the Nimesulide loaded in the sheath was released, in contrast to only 
about 20 % of the drug loaded in the core. Alongside DSC and TG data, the low levels of 
drug released suggest the presence of interactions between Nimesulide and the polymer 
matrices that contribute to the retention of the active. 
The release rates were also different, depending on the localization of the drug. In 
addition to diffusion path length, the nature of the polymer can also have an impact. In 
agreement with the literature, where it has been suggested that the incorporation and 
release of a drug from polymer matrices can be influenced by the glass transition 
temperature (Tg) of the polymer [54][55], a stronger burst effect was observed for the 
investigated fibers when Nimesulide was loaded in PCL (a polymer with low Tg, -60 ºC) 
than in PMMA (higher Tg, 118 ºC). The explanation offered for this effect is associated 
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with the effect of the rubbery state that can provide a lesser penetration of the low 
molecular weight drug into the nanopores present in the fibers; diffusion kinetics 
following a Fickian model have been observed in the first case, while a time dependent 
non-Fickian behavior was reported in the literature for the latter type of polymers, 
possibly because of the necessary rearrangement of the polymer chains so they can 
accommodate the diffusing drug molecules [54][55]. The results demonstrate clearly the 
ability of these PMMA/PCL coaxial fibers to control the different release rates and 
released drug levels depending on the localization of the active. 
 
Figure 8. Cumulative in vitro drug release profiles from: a) PMMA (core) / PCL and 
Nimesulide (sheath) fibers; b) PMMA and Nimesulide (core)/PCL (sheath) fibers. 
 
To assess the mechanism of Nimesulide release from the two types of drug-loaded 
coaxial fibers investigated, the experimental data was fitted to a number of kinetic models 
such as Hixon and Crowell, Higuchi, Peppas, Baker, first order, or Weibull (Table 6). 
According to the calculated correlation coefficients r2 (Table 5), the Nimesulide release 
data was found to be best described by the Weibull statistical model, typically useful for 
describing drug release from matrix-type systems. According to this model, a general 
function - represented in Equation (9) - can be applied successfully to describe the 
experimental release profiles, with the value of the exponent b indicative of the drug 
release mechanism [55][56]. 
 
F = 1-exp (𝑠𝑠𝑡𝑡𝑏𝑏 )         (9) 
 
where, F = the amount of the drug released; b = shape parameter, a = time 
parameter. Values of b below 0.75 indicate Fickian diffusion, values between 0.75 and 
1.0 indicate non-Fickian diffusion, while values above 1.0 indicate a complex drug release 
mechanism.  
The overall results suggest a Fickian diffusion mechanism for the release of 
Nimesulide from both types of drug-loaded core-sheath fibers, in agreement with 
literature reports that indicate that drug release from polymers with a very slow 
degradation rate (such as PCL) is typically controlled by diffusion [57][58]. 
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Table 6: Mathematical models and fitting parameters for the release profile of 
Nimesulide from the loaded core-sheath fibers. 
 
4 Conclusions 
Core-sheath fibers based on PMMA and PCL and differently loaded with the anti-
inflammatory drug Nimesulide were prepared successfully using a coaxial 
electrospinning technique. Combining PMMA with PCL in coaxial fibers overcomes 
some of the limitations of the former in terms of mechanical properties by improving 
characteristics such as elongation at break, and also increases the thermal stability of these 
fibers compared to that of the pure polymers. The water vapor permeability of the 
prepared core-sheath fiber mats was found to be higher compared to that of mats 
fabricated from normal, pure polymer fibers, with the inclusion of Nimesulide as a 
potential contributing factor. The release of Nimesulide was found to be controlled 
mainly by Fickian diffusion and to be strongly influenced by the location of the active in 
the drug-loaded, core-sheath fibers; the active was released faster and at a higher level 
(almost 50 % over 20 h) when loaded in the sheath compared to when it was located in 
the core (cumulative release 20 % over 20 h), with a reduced burst effect observed for the 
latter.  
The results suggest altogether that core-sheath fibers fabricated by coaxial 
electrospinning from hydrophobic polymers such as PMMA and PCL have improved 
properties compared to normal fibers obtained from pure polymers (particularly PMMA) 
and can be used to conveniently modulate the release of hydrophobic anti-inflammatory 
actives such as Nimesulide in prospective drug delivery applications. 
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Table 1: Parameters employed for the fabrication of normal and core-sheath fibers, with 
and without Nimesulide. 
Fibers 
Flow rate of 
PMMA or 
PMMA/Nimesulide 
solution (mL/h) 
Flow rate  
of PCL or 
PCL/Nimesulide 
solution (mL/h) 
Collector 
distance 
(cm) 
DC 
Voltage 
(kV) 
Normal  
PMMA 
6.0 - 16 6.0 
Normal  
PCL 
- 2.0 15 8.5 
PMMA/PCL 
without 
Nimesulide 
3.5 1.5 15 7.0 
PMMA (core) and 
PCL (sheath), with 
core-loaded 
Nimesulide 
3.5 1.2 15 7.0 
PMMA (core) and 
PCL (sheath), with 
sheath-loaded 
Nimesulide 
2.5 1.5 15 7.5 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Results for the diameter of the fibers. 
Fibers Diameter 
(mm) 
Normal PMMA  1.75 ± 0.13 a 
Normal PCL  1.49 ± 0.24 b 
PMMA (core) and 
PCL (sheath), with 
core-loaded 
Nimesulide 
4.48 ± 0.45 c 
PMMA (core) and 
PCL (sheath), with 
sheath-loaded 
Nimesulide 
3.83 ± 0.34 d 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. PS and EB values obtained for the coaxial fibers in comparison to normal 
fibers. 
Fibers Thickness 
(mm) 
Puncture 
strength (PS) 
(MPa) 
Elongation at 
break (EB) 
(%) 
Normal PMMA  0.255 ± 0.04 a 0.099 ± 0.03 a 0.125  ± 0.03 a 
Normal PCL  0.223 ± 0.05 a 0.662 ± 0.21 b 11.039 ± 2.22 b 
PMMA (core) and 
PCL (sheath), with 
core-loaded 
Nimesulide 
1.167 ± 0.02 b 0.279 ± 0.03 a 2.943 ± 0.32 a, c 
PMMA (core) and 
PCL (sheath), with 
sheath-loaded 
Nimesulide 
1.073 ± 0.03 c 0.242 ± 0.02 a 3.450 ± 0.92 c 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4. Results of contact angle measurements for normal and core-sheath fibers. 
Fibers Contact angle 
Normal PMMA 146 ± 1.4 a, c 
Normal PCL 152 ± 0.8 a 
PMMA (core) and PCL (sheath), 
with core-loaded Nimesulide 
125 ± 0.8 b, d 
PMMA (core) and PCL (sheath), 
with sheath-loaded Nimesulide 
122 ± 2.6 c, d 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5. Results of water vapor permeability (WVP) measurements. 
Fibers WVP 
(10-4 g.mm.h-1.m-2.KPa-1) 
Thickness 
(mm) 
Normal PMMA 0.39 ± 0.04 a 0.2538 ± 0.02 a 
Normal PCL 0.68 ± 0.06 a 0.5021 ± 0.04 b 
PMMA (core) and PCL (sheath), 
with core-loaded Nimesulide 
1.39 ± 0.13 b 0.3633 ± 0.04 a, c 
PMMA (core) and PCL (sheath), 
with sheath-loaded Nimesulide 
1.25 ± 0.04 b 0.3366 ± 0.01 c 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6: Mathematical models and curve fitting parameters for the Nimesulide release 
profiles (core-sheath fibers). 
Mathematical 
models 
PMMA (core) and PCL 
(shell), with shell-loaded 
Nimesulide 
PMMA (core) and PCL 
(shell), with core-loaded 
Nimesulide 
Hixon and 
Crowell 
r2 = 0.259 
k = 3x10-4 
r2 = 0.7123 
k = 6.84x10-5 
Higuchi 
r2 = 0.8223 
k = 1.7115 
r2 = 0.9396 
k = 0.5528 
Peppas 
r2 = 0.8839 
k = 3.9403 
n = 0.3656 
r2 = 0.9372 
k = 0.4096 
n = 0.5477 
Baker 
r2 = 0.8782 
k = 6.45x10-5 
r2 = 0.9378 
k = 5.43x10-6 
First order 
r2 = 0.4028 
k = 0.011 
r2 = 0.7282 
k = 0.0002 
Weibull 
r2 = 0.9955 
k = 9.17x10-2 
b = 0.01347 
r2 = 0.9989 
k = 41.0687 
b = 0.0113 
 








